Literature DB >> 29454621

The G protein-coupled receptors deorphanization landscape.

Céline Laschet1, Nadine Dupuis1, Julien Hanson2.   

Abstract

G protein-coupled receptors (GPCRs) are usually highlighted as being both the largest family of membrane proteins and the most productive source of drug targets. However, most of the GPCRs are understudied and hence cannot be used immediately for innovative therapeutic strategies. Besides, there are still around 100 orphan receptors, with no described endogenous ligand and no clearly defined function. The race to discover new ligands for these elusive receptors seems to be less intense than before. Here, we present an update of the various strategies employed to assign a function to these receptors and to discover new ligands. We focus on the recent advances in the identification of endogenous ligands with a detailed description of newly deorphanized receptors. Replication being a key parameter in these endeavors, we also discuss the latest controversies about problematic ligand-receptor pairings. In this context, we propose several recommendations in order to strengthen the reporting of new ligand-receptor pairs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Keywords:  Deorphanization; Drug target; G protein-coupled receptor; Orphan GPCR

Mesh:

Substances:

Year:  2018        PMID: 29454621     DOI: 10.1016/j.bcp.2018.02.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions.

Authors:  Céline Laschet; Nadine Dupuis; Julien Hanson
Journal:  J Biol Chem       Date:  2018-12-28       Impact factor: 5.157

Review 2.  New Insights in Cannabinoid Receptor Structure and Signaling.

Authors:  Lingyan Ye; Zheng Cao; Weiwei Wang; Naiming Zhou
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 3.  GPCR regulation of secretion.

Authors:  Yun Young Yim; Zack Zurawski; Heidi Hamm
Journal:  Pharmacol Ther       Date:  2018-07-26       Impact factor: 12.310

4.  Evaluating functional ligand-GPCR interactions in cell-based assays.

Authors:  Sheryl Sharma; James W Checco
Journal:  Methods Cell Biol       Date:  2021-07-29       Impact factor: 1.441

5.  Endocannabinoid-Binding Receptors as Drug Targets.

Authors:  María Gómez-Cañas; Carmen Rodríguez-Cueto; Valentina Satta; Inés Hernández-Fisac; Elisa Navarro; Javier Fernández-Ruiz
Journal:  Methods Mol Biol       Date:  2023

Review 6.  Advances in G protein-coupled receptor high-throughput screening.

Authors:  Emily A Yasi; Nicholas S Kruyer; Pamela Peralta-Yahya
Journal:  Curr Opin Biotechnol       Date:  2020-07-10       Impact factor: 9.740

7.  Repertoires of G protein-coupled receptors for Ciona-specific neuropeptides.

Authors:  Akira Shiraishi; Toshimi Okuda; Natsuko Miyasaka; Tomohiro Osugi; Yasushi Okuno; Jun Inoue; Honoo Satake
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

8.  Combining native and 'omics' mass spectrometry to identify endogenous ligands bound to membrane proteins.

Authors:  Joseph Gault; Idlir Liko; Michael Landreh; Denis Shutin; Jani Reddy Bolla; Damien Jefferies; Mark Agasid; Hsin-Yung Yen; Marcus J G W Ladds; David P Lane; Syma Khalid; Christopher Mullen; Philip M Remes; Romain Huguet; Graeme McAlister; Michael Goodwin; Rosa Viner; John E P Syka; Carol V Robinson
Journal:  Nat Methods       Date:  2020-05-04       Impact factor: 28.547

9.  The role of orphan receptor GPR139 in neuropsychiatric behavior.

Authors:  Maria Dao; Hannah M Stoveken; Yan Cao; Kirill A Martemyanov
Journal:  Neuropsychopharmacology       Date:  2021-01-21       Impact factor: 8.294

10.  Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin.

Authors:  Angela M Phillips; Michael B Doud; Luna O Gonzalez; Vincent L Butty; Yu-Shan Lin; Jesse D Bloom; Matthew D Shoulders
Journal:  Elife       Date:  2018-09-06       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.